
Elli Peselev
Examiner (ID: 2405)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1203, 1623, 2899, 1802, 1211, 1621, 1803 |
| Total Applications | 2819 |
| Issued Applications | 1827 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5801367
[patent_doc_number] => 20060035860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Resin composition with biodegradable non-liquid-crystalline and liquid-crystalline polymers'
[patent_app_type] => utility
[patent_app_number] => 11/251790
[patent_app_country] => US
[patent_app_date] => 2005-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3104
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035860.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251790
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251790 | Resin composition with biodegradable non-liquid-crystalline and liquid-crystalline polymers | Oct 17, 2005 | Issued |
Array
(
[id] => 5902461
[patent_doc_number] => 20060045874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Aminoglycoside treatment for lysosomal storage diseases'
[patent_app_type] => utility
[patent_app_number] => 11/244553
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8141
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20060045874.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244553 | Aminoglycoside treatment for lysosomal storage diseases | Oct 5, 2005 | Abandoned |
Array
(
[id] => 54403
[patent_doc_number] => 07767797
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-08-03
[patent_title] => 'Macrocyclic compounds and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/241514
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15950
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/767/07767797.pdf
[firstpage_image] =>[orig_patent_app_number] => 11241514
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/241514 | Macrocyclic compounds and methods of use thereof | Sep 29, 2005 | Issued |
Array
(
[id] => 8675046
[patent_doc_number] => 08383159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'Dosage forms having a microreliefed surface and methods and apparatus for their production'
[patent_app_type] => utility
[patent_app_number] => 11/236038
[patent_app_country] => US
[patent_app_date] => 2005-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 39
[patent_no_of_words] => 22848
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11236038
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/236038 | Dosage forms having a microreliefed surface and methods and apparatus for their production | Sep 26, 2005 | Issued |
Array
(
[id] => 826903
[patent_doc_number] => 07402568
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-22
[patent_title] => 'Bicyclic 9a-azalide derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/236043
[patent_app_country] => US
[patent_app_date] => 2005-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26708
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/402/07402568.pdf
[firstpage_image] =>[orig_patent_app_number] => 11236043
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/236043 | Bicyclic 9a-azalide derivatives | Sep 26, 2005 | Issued |
Array
(
[id] => 4853135
[patent_doc_number] => 20080318878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Antibacterial Agents'
[patent_app_type] => utility
[patent_app_number] => 11/576033
[patent_app_country] => US
[patent_app_date] => 2005-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13514
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318878.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576033
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576033 | Antibacterial Agents | Sep 26, 2005 | Abandoned |
Array
(
[id] => 5821044
[patent_doc_number] => 20060025357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus'
[patent_app_type] => utility
[patent_app_number] => 11/232930
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 14172
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20060025357.pdf
[firstpage_image] =>[orig_patent_app_number] => 11232930
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/232930 | Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus | Sep 22, 2005 | Abandoned |
Array
(
[id] => 5814846
[patent_doc_number] => 20060084624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'beta-L-2\'-deoxy-nucleosides for the treatment of hepatitis B'
[patent_app_type] => utility
[patent_app_number] => 11/232818
[patent_app_country] => US
[patent_app_date] => 2005-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17657
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084624.pdf
[firstpage_image] =>[orig_patent_app_number] => 11232818
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/232818 | β-L-2′-deoxy-nucleosides for the treatment of hepatitis B | Sep 21, 2005 | Issued |
Array
(
[id] => 4652151
[patent_doc_number] => 20080039407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Antibiotic and Method of Production Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/663408
[patent_app_country] => US
[patent_app_date] => 2005-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7840
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039407.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663408
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663408 | Antibiotic and method of production thereof | Sep 20, 2005 | Issued |
Array
(
[id] => 5716103
[patent_doc_number] => 20060079466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Rapamycin carbohydrate derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/229007
[patent_app_country] => US
[patent_app_date] => 2005-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13577
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079466.pdf
[firstpage_image] =>[orig_patent_app_number] => 11229007
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/229007 | Rapamycin carbohydrate derivatives | Sep 14, 2005 | Abandoned |
Array
(
[id] => 5614408
[patent_doc_number] => 20060116336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Lyophilized azithromycin formulation'
[patent_app_type] => utility
[patent_app_number] => 11/225767
[patent_app_country] => US
[patent_app_date] => 2005-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11796
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116336.pdf
[firstpage_image] =>[orig_patent_app_number] => 11225767
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/225767 | Lyophilized azithromycin formulation | Sep 12, 2005 | Abandoned |
Array
(
[id] => 914148
[patent_doc_number] => RE040040
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2008-01-29
[patent_title] => 'Process of use in converting the 4″(S)-OH functional group of the cladinose unit of an azamacrolide to 4″(R)-NH2'
[patent_app_type] => reissue
[patent_app_number] => 11/223912
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3353
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/040/RE040040.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223912 | Process of use in converting the 4″(S)-OH functional group of the cladinose unit of an azamacrolide to 4″(R)-NH2 | Sep 8, 2005 | Issued |
Array
(
[id] => 843625
[patent_doc_number] => 07388000
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-06-17
[patent_title] => 'Halide-free glucosamine phosphate compositions and methods of preparation'
[patent_app_type] => utility
[patent_app_number] => 11/223313
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3337
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/388/07388000.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223313
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223313 | Halide-free glucosamine phosphate compositions and methods of preparation | Sep 8, 2005 | Issued |
Array
(
[id] => 843626
[patent_doc_number] => 07388001
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-06-17
[patent_title] => 'Halide-free glucosamine sulfate compositions and methods of preparation'
[patent_app_type] => utility
[patent_app_number] => 11/223687
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3448
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/388/07388001.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223687
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223687 | Halide-free glucosamine sulfate compositions and methods of preparation | Sep 8, 2005 | Issued |
Array
(
[id] => 5177081
[patent_doc_number] => 20070178141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Vitamin B12 compositions'
[patent_app_type] => utility
[patent_app_number] => 11/219794
[patent_app_country] => US
[patent_app_date] => 2005-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3284
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178141.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219794
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219794 | Vitamin B12 compositions | Sep 6, 2005 | Abandoned |
Array
(
[id] => 5895407
[patent_doc_number] => 20060003946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Tetraphenylbacteriochlorin derivatives and compositions containing the same'
[patent_app_type] => utility
[patent_app_number] => 11/219853
[patent_app_country] => US
[patent_app_date] => 2005-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11581
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003946.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219853
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219853 | Tetraphenylbacteriochlorin derivatives and compositions containing the same | Sep 6, 2005 | Issued |
Array
(
[id] => 5649707
[patent_doc_number] => 20060135442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Pancreatic cancer treatment using Na+/K+ ATPase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/219638
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19191
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135442.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219638
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219638 | Pancreatic cancer treatment using Na+/K+ ATPase inhibitors | Sep 1, 2005 | Abandoned |
Array
(
[id] => 5649706
[patent_doc_number] => 20060135441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Combinatorial chemotherapy treatment using Na+/K+ ATPase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/219636
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11314
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135441.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219636
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219636 | Combinatorial chemotherapy treatment using Na+/K+ ATPase inhibitors | Sep 1, 2005 | Abandoned |
Array
(
[id] => 5904484
[patent_doc_number] => 20060046964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Pharmaceutical formulations and methods'
[patent_app_type] => utility
[patent_app_number] => 11/216042
[patent_app_country] => US
[patent_app_date] => 2005-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5399
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20060046964.pdf
[firstpage_image] =>[orig_patent_app_number] => 11216042
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/216042 | Pharmaceutical formulations and methods | Aug 31, 2005 | Abandoned |
Array
(
[id] => 5649733
[patent_doc_number] => 20060135468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Treatment of refractory cancers using NA+/K+ ATPase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/218332
[patent_app_country] => US
[patent_app_date] => 2005-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17602
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135468.pdf
[firstpage_image] =>[orig_patent_app_number] => 11218332
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/218332 | Treatment of refractory cancers using NA+/K+ ATPase inhibitors | Aug 31, 2005 | Abandoned |